文献速递神经核医学肿瘤 PET/CT

tau与淀粉样蛋白比值成像揭示阿尔茨海默病连续谱中阶段特异性区域分布

Stage-specific regional distribution of amyloid and tau deposition across the Alzheimer's disease continuum revealed by tau-to-amyloid ratio imaging.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2026-05-29

本研究基于BATON研究,对101例认知正常淀粉样蛋白阴性对照和102例AD连续谱患者(临床前AD 47例、AD所致MCI 24例、AD痴呆31例)行18F-flutemetamol淀粉样蛋白PET、18F-MK-6240 tau PET及3D MRI。结果显示淀粉样蛋白在临床前AD阶段已广泛沉积,而tau主要局限于内侧颞叶;tau/淀粉样蛋白比值(TAR)成像可捕捉这种阶段依赖性区域分离。

要点

  • 临床前AD阶段淀粉样蛋白已广泛沉积于额叶、后扣带/楔前叶和颞叶皮层。
  • 临床前AD阶段tau沉积主要局限于内侧颞叶,TAR在内侧颞叶皮层呈高值。
  • 进展至MCI和痴呆阶段,tau扩展至外侧颞叶、顶叶和额叶皮层,TAR呈现额叶下降及新皮层tau优势模式。

核心结论

  • 淀粉样蛋白和tau在AD连续谱中呈现 distinct 且阶段依赖的区域分离,TAR成像可有效捕捉这一差异。
  • TAR成像反映早期内侧颞叶tau优势及后续新皮层tau扩展,支持整合淀粉样蛋白-tau PET指标用于精细疾病分期和纵向治疗监测。

研究设计与样本

  • 分析BATON研究中在三个月内接受18F-flutemetamol淀粉样蛋白PET、18F-MK-6240 tau PET和3D MRI的参与者。
  • 参与者分为认知正常淀粉样蛋白阴性对照(CNA,n=101)和AD连续谱(n=102),后者包括临床前AD(PCA,n=47)、AD所致轻度认知障碍(MCA,n=24)和AD痴呆(ADD,n=31)。
  • 使用Centiloid和CenTauR框架计算标准化摄取值比(SUVR),并生成体素级tau/淀粉样蛋白比值(TAR)图像,进行体素级和感兴趣区分析比较各阶段区域模式。

主要发现

  • 淀粉样蛋白沉积在PCA阶段已广泛分布,涉及额叶、后扣带/楔前叶和颞叶皮层。
  • PCA阶段tau沉积主要局限于内侧颞叶;进展至MCA和ADD阶段,tau负荷显著增加并扩展至外侧颞叶、顶叶和额叶皮层。
  • TAR分析显示PCA阶段内侧颞叶皮层TAR高值,MCA阶段额叶区域TAR下降,ADD阶段呈现tau优势的新皮层模式。

临床怎么用

  • 整合淀粉样蛋白-tau PET指标(如TAR)可能有助于细化AD疾病分期。
  • TAR成像可反映早期内侧颞叶tau优势及后续新皮层tau扩展,或可用于纵向治疗监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amyloid-β and tau deposition follow distinct spatial and temporal trajectories across the Alzheimer's disease (AD) continuum. Amyloid accumulation occurs early in the disease course, whereas tau pathology is more closely associated with neurodegeneration and clinical progression. Characterizing stage-specific regional divergence between amyloid and tau deposition may refine biomarker-based disease staging and improve prognostic assessment. METHODS: We analyzed participants from the BATON study who underwent amyloid PET with 18F-flutemetamol, tau PET with 18F-MK-6240, and 3D MRI within a three-month interval. Participants were classified into cognitively normal amyloid-negative controls (CNA, n = 101) and the AD continuum (n = 102), comprising preclinical AD (PCA, n = 47), mild cognitive impairment due to AD (MCA, n = 24), and AD dementia (ADD, n = 31). Standardized uptake value ratios (SUVRs) were calculated using the Centiloid and CenTauR frameworks, and voxel-wise tau-to-amyloid ratio (TAR) images were generated. Voxel-wise and region-of-interest analyses were performed to compare regional patterns of amyloid deposition, tau accumulation, and TAR across disease stages. RESULTS: Amyloid deposition was already widespread at the PCA stage, involving the frontal, posterior cingulate/precuneus, and temporal cortices. In contrast, tau deposition in PCA was largely confined to the medial temporal lobe. With progression to MCA and ADD, tau burden increased substantially and extended to the lateral temporal, parietal, and frontal cortices. TAR analysis demonstrated high values in the medial temporal cortex at the PCA stage, followed by decreasing TAR in frontal regions during MCA and a tau-dominant neocortical pattern in ADD. CONCLUSIONS: Amyloid and tau exhibit distinct and stage-dependent regional dissociation across the AD continuum. TAR imaging effectively captures this divergence, reflecting early medial temporal tau predominance and subsequent neocortical tau expansion. These findings support the utility of integrated amyloid-tau PET metrics for refined disease staging and longitudinal therapeutic monitoring.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Ishii K, Yamada T, Hanaoka K, et al. Stage-specific regional distribution of amyloid and tau deposition across the Alzheimer's disease continuum revealed by tau-to-amyloid ratio imaging. Eur J Nucl Med Mol Imaging. 2026. PMID: 42209819. doi:10.1007/s00259-026-07935-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。